Double multi-cancer detection rate shown in the earliest stage using Elypta MIRAM® kit
Stockholm, Dec 7, 2022: Swedish cancer detection company Elypta today announces the publication of groundbreaking research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr. Francesco Gatto, showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumor metabolism. The research has been published in the peer-reviewed journal Proceedings of the National Academy of Sciences (PNAS)."These results made us realize that there is an opportunity to commercialize a highly differentiated MCED test with industry-